Abstract
A two-stage method for the preparation of 2-(3-carboxymethylindazol-1-yl)anilines using the N-arylation reaction of 3-carboxymethylindazoles with o-nitrohaloarenes and subsequent reduction of nitro-containing intermediates with tin(II) chloride was developed. The experimental results showed that the use of the synthesized compounds as fluorophores in the visible region of the spectrum is promising.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
N-Substituted indazole derivatives have attracted considerable interest of researchers for a long time. They have been found among the alkaloids of black cumin [1, 2]. These compounds are used as antiemetics (granisetron, tropisetron) [3], anticancer drugs (niraparib, pazopanib) [4], anti-inflammatory agents (benzadac, benzydamine) [5, 6]. Biological activity of N-substituted indazole derivatives have been reviewed in detail in [7–9].
In addition, a wide range of useful photophysical properties of N-substituted indazoles should be noted. They are used in lighting technology, for light-emitting devices production, as well as in study of biochemical processes in living systems using fluorescent trackers [10–13].
Due to great practical importance of N-arylated indazoles, over the past two decades methods for their design have been studied in detail and developed using both base and transition metal catalysis [14–19]. N-Arylation reactions of 1H-indazoles can proceed at both nitrogen atoms [14–16]. However, as a rule, the reaction proceeds regioselectively at the N1 atom of the indazole ring [17–19]. At the same time, despite a significant data on this topic, only a single publication is devoted to the reaction of N-arylation of indazole-3-carboxylates [20].
Earlier, we have found unusual regioselectivity in the N-arylation reaction of pyrazole-3-carboxylates when using O-nitro-substituted haloarenes [21]. Under the reaction conditions, a predominant nucleophilic substitution at the N2 atom of the pyrazole ring was observed. Subsequent reduction of the nitro derivative with tin(II) chloride and other reagents [22] in all cases gave N-hydroxyquinoxalines as the products of reductive cyclization. The obtained compounds showed the properties of potent and selective inhibitors of human monoamine oxidase [23]. Herein, we attempted to aply this approach to the synthesis of fused systems containing indazole and quinoxaline rings.
To accomplish this task, methyl indazole-3-carboxylate was reacted with a number of electron-deficient O-nitrohaloarenes in absolute DMF in the presence of anhydrous potassium carbonate as a deprotonating agent (Scheme 1). However, it was found that the N-arylation of indazole-3-carboxylates proceeds at the N1 atom of the indazole ring to give the corresponding N-aryl derivatives 3а–3h with yields up to 97%. Despite attempts to vary the reaction conditions (temperature, solvent), the use of deprotonating agents of different nature (potassium tert-butoxide, triethylamine, 4-N,N-dimethylaminopyridine) failed to detect the formation of isomeric compounds 2.
The obtained series of nitro derivatives 3а–3h was converted into the corresponding amines 4а–4h using the previously developed method for the reduction of N-nitroarylpyrazole-3-carboxylates with tin(II) chloride in ethanol in the presence of hydrochloric acid [21] (Scheme 2). Compounds 4a–4h were obtained in yields of 58–88%.
A series of heterocyclic amines 4a–4h containing various functional groups was investigated for the presence of photoluminescence in the solid state at room temperature using a Fluorolog 3 fluorescence spectrometer. The found emission spectral maxima (λemmax), the excited state lifetime (τ) and the chromaticity diagram parameters (CIE [x; y]) are given in Table 1. The emission spectra recorded upon irradiation with light λem 450 nm are shown in Fig. 1.
The obtained data showed that compounds 4a–4h possess strong yellow-green photoluminescence in the solid state. The emission spectra are mainly represented by a wide band. Luminescence maxima are in the range from 487 to 540 nm. The largest shift of the maximum occurs when hydrogen (4a) is replaced by a nitrile group (4e) at position 4. The lifetimes of the excited state for compounds 4b, 4d–4h do not differ from each other and are in the range from 0.4 to 4.4 nsec. A sharp difference is observed for compounds 4а and 4c, for which the excited state lifetime is 653 and 518 ns, respectively. Such a sharp increase in the excited state lifetime may be explained by more dense molecular packing due to the strong intermolecular dipole-dipole interaction [24, 25].
In conclusion, a series of new 2-(3-carboxymethylindazol-1-yl)anilines was synthesized by a two-step method, including N-arylation of 3-carboxymethylindazoles with o-nitrohaloarenes followed by the reduction of nitro-containing intermediates. The proposed approach provides the overall yield of the target amino derivatives in 62–78% range. The obtained compounds are of interest as organic fluorophores with emission in the yellow-green spectral region.
EXPERIMENTAL
Organic, inorganic reagents and solvents were obtained from commercial sources (Aldrich, Vekton, Ekros) and were used without additional purification. The reaction progress was monitored by thin layer chromatography (TLC) on silica gel on Silufol UV aluminum plates eluting with a mixture of ethyl acetate and petroleum ether (1 : 1). NMR spectra were recorded on a Varian XL-400 instrument (400 MHz) in DMSO-d6 solutions at 25°C. Melting points were determined on a Büchi M-560 melting point and boiling point apparatus. High-resolution mass spectra were recorded on a Bruker Daltonics MicrOTOF-II instrument, the ionization method was electrospray ionisation (ESI), the temperature of the ionization source was 180°C, the eluent was methanol. Photoluminescence spectra, excited state lifetimes were obtained on a Fluorolog 3 fluorescence spectrometer (Horiba Jobin Yvon).
General procedure for the synthesis of methyl 1-(2-nitroaryl)-1H-indazole-3-carboxylates 3а–3h. To a solution of 1H-indazole-3-carboxylate (1 mmol) in DMF (1.5 mL) was added the corresponding O-nitrohaloarene (1 mmol) and K2CO3 (1.3 mmol). The reaction mixture was stirred at 70–100°С for 12 h. After the reaction completed, the resulting suspension was diluted with 7 mL of distilled water, the precipitate was filtered off and washed with 2 mL of water. The resulting product was purified by recrystallization from an ethanol–DMF mixture.
Methyl 1-(2-nitrophenyl)-1H-indazole-3-carboxylate (3a). Yield 0.276 g (93%), pale yellow crystals, mp 163–165°С. 1Н NMR spectrum, δ, ppm: 3.97 s (3H, СН3), 7.49 d. t (1H, Ar, J 8.4, 2.0 Hz), 7.61 d. d (2H, Ar, J 4.0, 2.0 Hz), 7.87 d. t (1H, Ar, J 8.8, 2.0 Hz), 7.93–8.07 m (2H, Ar), 8.22 d (1H, Ar, J 8.4 Hz), 8.27 d (1H, Ar, J 8.4 Hz). 13C NMR spectrum, δ, ppm: 52.06, 110.43, 121.68, 123.01, 124.26, 125.92, 128.50, 128.55, 130.64, 130.70, 134.61, 137.18, 140.78, 145.04, 161.81. Mass spectrum, m/z: 320.0643 [M + Na]+ (calcd for C15H11N3NaO4: 320.0642).
Methyl 1-(4-cyano-2-nitrophenyl)-1H-indazole-3-carboxylate (3b). Yield 0.299 g (93%), pale yellow powder, mp 230–232°С. 1Н NMR spectrum, δ, ppm: 3.97 s (3H, СН3), 7.53 s (1H, Ar), 7.66 s (1H, Ar), 7.76 s (1H, Ar), 8.23 d (1H, Ar, J 8.0 Hz), 8.31 d (1H, Ar, J 8.4 Hz), 8.49 d (1H, Ar, J 8.4 Hz), 8.87 s (1H, Ar). 13C NMR spectrum, δС, ppm: 52.36, 110.80, 112.61, 116.51, 121.97, 123.31, 124.86, 128.90, 129.07, 130.36, 134.11, 138.24, 138.36, 140.48, 144.66, 161.62. Mass spectrum, m/z: 345.0596 [M + Na]+ (calcd for C16H10N4NaO4: 345.0594).
Methyl 1-(2,4-dinitrophenyl)-1H-indazole-3-carboxylate (3c). Yield 0.332 g (97%), yellow powder, mp 186–189°С. 1Н NMR spectrum, δ, ppm: 3.98 s (3H, СН3), 7.54 t (2H, Ar, J 7.6 Hz), 7.68 t (1H, Ar, J 7.6 Hz), 7.78 d (1H, Ar, J 8.0 Hz), 8.24 d (1H, Ar, J 7.6 Hz), 8.37 d (1H, Ar, J 8.8 Hz), 8.75 d (1H, Ar, J 8.4 Hz), 9.00 s (1H, Ar). 13C NMR spectrum, δС, ppm: 52.28, 110.66, 121.80, 122.00, 123.34, 124.85, 128.85, 129.08, 135.22, 138.57, 140.44, 144.26, 146.65, 161.49. Mass spectrum, m/z: 365.0493 [M + Na]+ (calcd for C15H10N4NaO6: 365.0493).
Methyl 1-[4-(ethoxycarbonyl)-2-nitrophenyl]-1H-indazole-3-carboxylate (3d). Yield 0.302 g (82%), pale yellow powder, mp 158–161°С. 1Н NMR spectrum, δ, ppm: 1.39 t (3H, СН3, СН3, J 7.2 Hz), 3.97 s (3H, СН3), 4.43 q (2H, СН2, J 7.2 Hz), 7.52 t (1H, Ar, J 7.6 Hz), 7.64 t (1H, Ar, J 7.6 Hz), 7.71 d (1H, Ar, J 8.4 Hz), 8.22 t (2H, Ar, J 8.4 Hz), 8.47 d (1H, Ar, J 8.4 Hz), 8.65 s (1H, Ar). 13C NMR spectrum, δС, ppm: 14.01, 52.21, 61.95, 110.59, 121.89, 123.23, 124.63, 126.49, 128.66, 128.86, 131.08, 134.07, 134.56, 137.99, 140.51, 144.56, 161.65, 163.33. Mass spectrum, m/z: 392.0850 [M + Na]+ (calcd for C18H15N3NaO6: 392.0853).
Methyl 1-[2-nitrophenyl-4-(trifluoromethyl)]-1Hindazole-3-carboxylate (3e). Yield 0.328 g (90%), beige crystals, mp 182–185°С. 1Н NMR spectrum, δ, ppm: 3.98 s (3H, СН3), 7.53 t (1H, Ar, J 7.6 Hz), 7.65 t (1H, Ar, J 7.6 Hz), 7.76 d (1H, Ar, J 8.0 Hz), 8.24 d (1H, Ar, J 8.0 Hz), 8.32 d (1H, Ar, J 8.4 Hz), 8.39 d (1H, Ar, J 8.4 Hz), 8.68 s (1H, Ar). 13C NMR spectrum, δС, ppm: 52.92, 111.33, 122.00, 122.58, 123.92, 125.36, 129.58, 130.82, 131.93, 134.55, 138.83, 145.59, 162.31. Mass spectrum, m/z: 388.0516 [M + Na]+ (calcd for C16H10F3N3NaO4: 388.0516).
Methyl 1-[4-(morpholin-4-ylsulfonyl)-2-nitrophenyl]-1H-indazole-3-carboxylate (3f). Yield 0.343 g (77%), yellow powder, mp 226–230°С. 1Н NMR spectrum, δ, ppm: 3.10 s (4H, CH2), 3.69 s (4H, CH2), 3.98 s (3H, СН3), 7.54 t (1H, Ar, J 7.6 Hz), 7.66 t (1H, Ar, J 7.6 Hz), 7.81 d (1H, Ar, J 8.4 Hz), 8.18 – 8.34 m (3H, Ar), 8.49 s (1H, Ar) 13C NMR spectrum, δС, ppm: 52.29, 110.86, 121.92, 123.26, 124.76, 125.33, 128.87, 129.48, 133.10, 134.25, 135.97, 138.22, 140.57, 144.72, 161.64. Mass spectrum, m/z: 469.0787 [M + Na]+ (calcd for C19H18N4NaO7S: 469.0788).
Methyl 1-(3-nitropyridin-2-yl)-1H-indazole-3-carboxylate (3g). Yield 0.229 g (77%), pale yellow crystals, mp 143–146°С. 1Н NMR spectrum, δ, ppm: 3.97 s (3H, СН3), 7.55 t (1H, Ar, J 7.6 Hz), 7.70 t (1H, Ar, J 7.6 Hz), 7.78–7.89 m (1H, Ar), 8.23 d (1H, Ar, J 8.0 Hz), 8.27 d (1H, Ar, J 8.4 Hz), 8.68 d (1H, Ar, J 8.0 Hz), 8.93 d (1H, Ar, J 4.4 Hz). 13C NMR spectrum, δС, ppm: 52,36, 113.32, 121.76, 123.52, 124.13, 125.13, 129.14, 135.57, 138.41, 139.51, 139.72, 142.64, 151.82, 161.46. Mass spectrum, m/z: 321.0598 [M + Na]+ (calcd for C14H10N4NaO4: 321.0594).
Methyl 1-(5-bromo-3-nitropyridin-2-yl)-1H-indazole-3-carboxylate (3h). Yield 0.312 g (83%), orange crystals, mp 159–162°С. 1Н NMR spectrum, δ, ppm: 3.96 s (3H, СН3), 7.54 t (1H, Ar, J 7.2 Hz), 7.69 t (1H, Ar, J 8.0 Hz), 8.21 d (1H, Ar, J 8.4 Hz), 8.25 d (1H, Ar, J 8.8 Hz), 9.02 s (1H, Ar), 9.07 s (1H, Ar). 13C NMR spectrum, δС, ppm: 52.37, 117.90, 121.80, 123.53, 125.25, 137.53, 138.74, 139.08, 139.64, 141.44, 161.32. Mass spectrum, m/z: 398.9705 [M + Na]+ (calcd for C14H9BrN4NaO4: 398.9699).
General procedure for the synthesis of methyl 1-(2-aminoaryl)-1H-indazole-3-carboxylates 4a–4h. To a mixture of SnCl2 (3.5 mmol) in conc. HCl (2 mL) and ethanol (2 mL) was added the corresponding 1-(2-nitroaryl)-1H-indazole-3-carboxylate 3 (0.01 mol). The reaction mixture was stirred at 50°C for 3–4 h. The precipitate was filtered off, washed with ethanol, and recrystallized from an ethanol–DMF mixture.
Methyl 1-(2-aminophenyl)-1H-indazole-3-carboxylate (4a). Yield 0.225 g (84%), pale yellow powder, mp 128–130°С. 1Н NMR spectrum, δ, ppm: 3.96 s (3H, СН3), 5.13 s (2H, NH2), 6.72 t (1H, Ar, J 7.2 Hz), 6.96 d (1H, Ar, J 8.0 Hz), 7.20 d (1H, Ar, J 7.6 Hz), 7.26 t (1H, Ar, J 7.6 Hz), 7.34 d (1H, Ar, J 8.4 Hz), 7.41 t (1H, Ar, J 7.2 Hz), 7.50 t (1H, Ar, J 7.6 Hz), 8.18 d (1H, Ar, J 8.0 Hz). 13C NMR spectrum, δС, ppm: 51.75, 111.15, 116.73, 116.93, 121.35, 123.04, 123.48, 127.39, 130.05, 135.76, 140.91, 143.36, 162.32. Mass spectrum, m/z: 290.0908 [M + Na]+ (calcd for C15H13N3NaO2: 290.0900).
Methyl 1-(2-amino-4-cyanophenyl)-1H-indazole-3-carboxylate (4b). Yield 0.169 g (59%), pale yellow powder, mp 176–182°С. 1Н NMR spectrum, δ, ppm: 3.96 s (3H, СН3), 5.69 s (1H, NH2), 7.10 d (1H, Ar, J 8.0 Hz), 7.31 s (1H, Ar), 7.38–7.44 m (3H, Ar), 7.53 t (1H, Ar, J 7.6 Hz), 8.19 d (1H, Ar, J 8.0 Hz). 13C NMR spectrum, δС, ppm: 51.91, 111.14, 112.44, 118.67, 118.83, 119.27, 121.52, 123.18, 123.77, 125.89, 127.78, 128.86, 136.55, 140.73, 145.07, 162.20. Mass spectrum, m/z: 315.0856 [M + Na]+ (calcd for C16H12N4NaO2: 315.0852).
Methyl 1-(2,4-diaminophenyl)-1H-indazole-3-carboxylate (4c). Yield 0.173 g (61%), white powder, mp 176–180°С. 1Н NMR spectrum, δ, ppm: 3.95 s (3H, СН3), 4.67 s (2H, NH2), 5.20 s (2H, NH2), 5.98 d (1H, Ar, J 8.4 Hz), 6.11 s (1H, Ar), 6.83 d (1H, Ar, J 8.0 Hz), 7.31 d (1H, Ar, J 8.4 Hz), 7.34–7.41 m (1H, Ar), 7.46 т (1H, Ar, J 7.6 Hz), 8.14 d (1H, Ar, J 8.0 Hz). 13C NMR spectrum, δС, ppm: 51.63, 100.61, 101.02, 104.03, 111.24, 113.73, 121.16, 122.87, 123.22, 127.01, 127.98, 141.29, 144.76, 148.53, 162.42. Mass spectrum, m/z: 305.1014 [M + Na]+ (calcd for C15H14N4NaO2: 305.1009).
Methyl 1-[2-amino-4-(ethoxycarbonyl)phenyl]-1H-indazole-3-carboxylate (4d). Yield 0.299 g (88%), beige powder, mp 130–135°С. 1Н NMR spectrum, δ, ppm: 1.35 t (3H, СН3, J 6.8 Hz), 3.97 s (3H, СН3), 4.34 q (2H, СН2, J 7.2 Hz,), 5.49 s (2H, NH2), 7.28 d (1H, Ar, J 8.0 Hz), 7.33–7.46 m (3H, Ar), 7.53 t (1H, Ar, J 7.6 Hz), 7.61 s (1H, Ar), 8.20 d (1H, Ar, J 8.0 Hz). 13C NMR spectrum, δC, ppm: 166.17, 162.94, 145.01, 141.44, 136.95, 131.87, 128.40, 128.35, 126.60, 124.37, 123.84, 122.17, 117.84, 117.06, 111.94, 61.49, 52.54, 14.87. Mass spectrum, m/z: 362.1151 [M + H]+ (calcd for C18H17N3NaO4: 362.1111).
Methyl 1-[2-amino-4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxylate (4e). Yield 0.195 g (58%), pale yellow powder, mp 154–157°С. 1Н NMR spectrum, δ, ppm: 3.97 s (3H, СН3), 4.92 s (2H, NH2), 6.99 d (1H, Ar, J 8.4 Hz), 7.29 s (1H, Ar), 7.38–7.45 m (3H, Ar), 7.52 t (1H, Ar, J 7.6 Hz), 8.20 d (1H, Ar, J 8.0 Hz). 13C NMR spectrum, δC, ppm: 52.53, 111.82, 112.48, 113.32, 122.17, 123.85, 124.37, 125.86, 126.09, 128.38, 129.35, 130.98, 131.29, 141.52, 145.68, 162.93. Mass spectrum, m/z: 358.0775 [M + Na]+ (calcd for C16H12F3N3NaO2: 358.0774).
Methyl 1-[2-amino-4-(morpholin-4-ylsulfonyl)phenyl]-1H-indazole-3-carboxylate (4f). Yield 0.337 g (81%), pale yellow crystals, mp 227–231°С. 1Н NMR spectrum, δ, ppm: 2.98 s (4H, Alk), 3.68 s (4H, Alk), 3.98 s (3H, СН3), 5.75 s (2H, NH2), 7.00 d (1H, Ar, J 8.0 Hz), 7.35 s (1H, Ar), 7.41–7.57 m (4H, Ar), 8.21 d (1H, Ar, J 7.6 Hz). 13C NMR spectrum, δC, ppm: 45.93, 51.86, 65.35, 111.25, 114.21, 115.00, 121.47, 123.15, 123.73, 125.65, 127.70, 128.52, 135.70, 136.47, 140.78, 145.02, 162.21. Mass spectrum, m/z: 439.1053 [M + Na]+ (calcd forC19H20N4NaO5S: 439.1047).
Methyl 1-(3-aminopyridin-2-yl)-1H-indazole-3-carboxylate (4g). Yield 0.183 g (68%), beige powder, mp 145–149°С. 1Н NMR spectrum, δ, ppm: 3.99 s (3H, СН3), 5.96 s (2H, NH2), 7.20–7.31 m (1H, Ar), 7.40 d (1H, Ar, J 8.0 Hz), 7.46 t (1H, Ar, J 7.2 Hz), 7.57 t (1H, Ar, J 7.6 Hz), 7.86 d. d (1H, Ar, J 4.4, 2.0 Hz), 8.10 d (1H, Ar, J 8.4 Hz), 8.21 d (1H, Ar, J 8.0 Hz). 13C NMR spectrum, δC, ppm: 51.97, 113.86, 121.19, 122.80, 124.17, 124.24, 124.74, 127.81, 135.16, 136.21, 137.91, 140.29, 162.01. Mass spectrum, m/z: 291.0854 [M + Na]+ (calcd for C14H12N4NaO2: 291.0852).
Methyl 1-(3-amino-5-bromopyridin-2-yl)-1H-indazole-3-carboxylate (4h). Yield 0.264 g (76%), yellow powder, mp 176–180°С. 1Н NMR spectrum, δ, ppm: 3.99 s (3H, СН3), 6.23 s (2H, NH2), 7.47 t (1H, Ar, J 7.6 Hz), 7.54–7.65 m (2H, Ar), 7.92 s (1H, Ar), 8.09 d (1H, Ar, J 8.0 Hz), 8.21 d (1H, Ar, J 7.6 Hz). 13C NMR spectrum, δC, ppm: 52.01, 113.76, 119.06, 121.26, 122.80, 124.32, 125.85, 128.00, 134.74, 135.04, 135.55, 139.34, 140.23, 161.87. Mass spectrum, m/z: 368.9960 [M + Na]+ (calcd for C14H11BrN4NaO2: 368.9958).
REFERENCES
Liu, Y.M., Yang, J.S., and Liu, Q.H., Chem. Pharm. Bull., 2004, vol. 52, p. 454. https://doi.org/10.1248/cpb.52.454
Atta-ur-Rahman Malik, S., Hasan, S.S., Choudhary, M.I., Ni, C.-Z., and Clardy, J., Tetrahedron Lett., 1995, vol. 36, p. 1993. https://doi.org/10.1016/0040-4039(95)00210-4
Fischer, J. and Ganellin, C.R., John Wiley & Sons, 2006, p. 448. https://doi.org/10.1002/3527608001
Scott, L.J., Drugs, 2017, vol. 77, p. 1029. https://doi.org/10.1007/s40265-017-0752-y
Shen, T.Y., Ann. Rep. Med. Chem., 1968, vol. 3, p. 215. https://doi.org/10.1016/S0065-7743(08)61326-3
Gaikwad, D.D., Chapolikar, A.D., Devkate, C.G., Warad, K.D., Tayade, A.P., Pawar, R.P., and Domb, A.J., Eur. J. Med. Chem., 2015, vol. 90, p. 707. https://doi.org/10.1016/j.ejmech.2014.11.029
Dong, J., Zhang, Q., Wang, Z., Huang, G., and Li, S., ChemMedChem, 2018, vol. 13, no. 15, p. 1490. https://doi.org/10.1002/cmdc.201800253
Wan, Y.C., He, S.Z., Li, W., and Tang, Z.L., Anti-Cancer Agents Med. Chem., 2018, vol. 18, p. 1228.
Zhang, S.G., Liang, C.G., and Zhang, W.H., Molecules, 2018, vol. 23, no. 11, p. 2783. https://doi.org/10.3390/molecules23112783
Kim, O.S., Jang, J.H., Kim, H.T., Han, S.J., Tsui, G.C., and Joo, J.M., Org. Lett., 2017, vol. 19, no. 6, p. 1450. https://doi.org/10.1021/acs.orglett.7b00410
Janardhanan, J.C., Mishra, R.K., Das, G., Sini, S., Jayamurthy, P., Suresh, C.H., Praveen, V.K., Manoj, N., and Babu, B.P., Asian J. Org. Chem., 2018, vol. 7, p. 2094. https://doi.org/10.1002/ajoc.201800413
Pakjoo, V., Roshani, M., Pordel, M., and Hoseini, T., Arkivoc, 2012, vol. 9, p. 195. https://doi.org/10.3998/ark.5550190.0013.917
Cheng, Y., Li, G., Liu, Y., Shi, Y., Gao, G., Wu, D., Lan, J., and You, J., J. Am. Chem. Soc., 2016, vol. 138, no. 14, p. 4730. https://doi.org/10.1021/jacs.5b09241
Ding, X., Bai, J., Wang, H., Zhao, B., Li, J., and Ren, F., Tetrahedron, 2017, vol. 73, p. 172. https://doi.org/10.1016/j.tet.2016.11.066
Zhang, R., Liu, Z., Peng, Q., Zhou, Y., Xu, L., and Pan, X., Org. Biomol. Chem., 2018, vol. 16, p. 1816. https://doi.org/10.1039/c8ob00128f
Xu, L., Du, S., Li, Z., and Tian, Z., Heterocycles, 2018, vol. 96, no. 1, p. 74. https://doi.org/10.3987/com-17-13826
Liang, Y., Zhang, X., and MacMillan, D.W.C., Nature, 2018, vol. 559, p. 83. https://doi.org/10.1038/s41586-018-0234-8
Antilla, J.C., Baskin, J.M., Barder, T.E., and Buchwald, S.L., J. Org. Chem., 2004, vol. 69, no. 17, p. 5578. https://doi.org/10.1021/jo049658b
Gamonal, A., Brunet, E., Juanes, O., and RodriguezUbis, J.C., J. Photochem. Photobiol. (A), 2017, vol. 342, p. 53. https://doi.org/10.1016/j.jphotochem.2017.03.037
Reddy, A.V., Gogireddy, S., Dubey, P.K., Reddy, M.B., and Veeresh, B., J. Chem. Sci., 2015, vol. 127, p. 433. https://doi.org/10.1007/s12039-015-0792-3
Panova, V.A., Korsakov, M.K., Shetnev, A.A., and Filimonov, S.I., Mendeleev Commun., 2019, vol. 29, no. 1, p. 114. https://doi.org/10.1016/j.mencom.2019.01.039
Panova, V.A., Ivanovskii, S.A., Shetnev, A.A. Chirkova, Zh,V., Sudzilovskaya, T.N., and Filimonov, S.I., Russ. Chem. Bull., 2020, vol. 69, p. 1965. https://doi.org/10.1007/s11172-020-2986-1
Panova, V.A., Filimonov, S.I., Chirkova, Zh.V., Kabanova, M.V., Shetnev, A.A., Korsakov, M.K., Petzer, A., and Petzer, J.P., Bioorg. Chem., 2020, vol. 108, p. 104563. https://doi.org/10.1016/j.bioorg.2020.104563
Gierschner, J. and Park, S.Y., J. Mater. Chem. (C), 2013, vol. 1, p. 5818. https://doi.org/10.1039/C3TC31062K
Nishio, S., Higashiguchi, K., and Matsuda, K., Asian J. Org. Chem., 2014, vol. 3, p. 686. https://doi.org/10.1002/ajoc.201402024
Funding
This work was financially supported by the Russian Science Foundation (project no. 20-73-00203) using the equipment of the Resource Centers “Chemical Analysis and Materials Research Center” and “Center for Optical and Laser Materials Research” of St. Petersburg State University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
No conflict of interest was declared by the authors.
Additional information
Translated from Zhurnal Obshchei Khimii, 2021, Vol. 91, No. 6, pp. 862–868 https://doi.org/10.31857/S0044460X21060044.
Rights and permissions
Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shetnev, A.A., Panova, V.A., Kutuzova, P.M. et al. Synthesis and Photoluminescent Properties of 2-(3-Carboxymethylindazol-1-yl)anilines. Russ J Gen Chem 91, 985–990 (2021). https://doi.org/10.1134/S1070363221060049
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363221060049